GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chemical Works of Gedeon Richter PLC (BUD:RICHTER) » Definitions » Total Stockholders Equity

Chemical Works of Gedeon Richter (BUD:RICHTER) Total Stockholders Equity : Ft1,130,814 Mil (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Chemical Works of Gedeon Richter Total Stockholders Equity?

Chemical Works of Gedeon Richter's Total Stockholders Equity for the quarter that ended in Dec. 2023 was Ft1,130,814 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Chemical Works of Gedeon Richter's Book Value per Share for the quarter that ended in Dec. 2023 was Ft6,186.99. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Chemical Works of Gedeon Richter's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.02.


Chemical Works of Gedeon Richter Total Stockholders Equity Historical Data

The historical data trend for Chemical Works of Gedeon Richter's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemical Works of Gedeon Richter Total Stockholders Equity Chart

Chemical Works of Gedeon Richter Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 717,981.00 806,957.00 914,886.00 1,063,401.00 1,130,814.00

Chemical Works of Gedeon Richter Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,063,401.00 1,088,455.00 1,038,948.00 1,083,486.00 1,130,814.00

Chemical Works of Gedeon Richter  (BUD:RICHTER) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Chemical Works of Gedeon Richter's Book Value per Share for the quarter that ended in Dec. 2023 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Chemical Works of Gedeon Richter's Debt-to-Equity for the quarter that ended in Dec. 2023 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chemical Works of Gedeon Richter Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Chemical Works of Gedeon Richter's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Chemical Works of Gedeon Richter (BUD:RICHTER) Business Description

Traded in Other Exchanges
Address
Gyomroi ut 19-21, Budapest, HUN, 1103
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular and central nervous system products. It manufactures medicines including original, generic and licenced products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharmaceuticals segment comprising the research and development, manufacturing, sales and marketing of pharmaceutical products, and Wholesale and Retail segment for the products of the company. The company operates internationally and the majority of its revenue is generated from the Pharmaceuticals segment.

Chemical Works of Gedeon Richter (BUD:RICHTER) Headlines

No Headlines